ARCH Venture Management, LLC - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 201 filers reported holding KARUNA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.9%.

Quarter-by-quarter ownership
ARCH Venture Management, LLC ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$5,449,200
-94.6%
30,000
-94.2%
2.63%
-89.8%
Q4 2022$100,779,348
-65.9%
512,872
-60.9%
25.81%
-32.6%
Q3 2022$295,304,000
-19.9%
1,312,872
-54.9%
38.28%
-14.7%
Q2 2022$368,507,000
-0.2%
2,912,8720.0%44.90%
-14.9%
Q1 2022$369,323,000
-3.2%
2,912,8720.0%52.78%
+30.7%
Q4 2021$381,586,0002,912,87240.37%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 782,008$142,043,93358.49%
Nan Fung Group Holdings Ltd 225,688$40,993,96827.90%
Sofinnova Investments, Inc. 1,773,124$322,070,24320.60%
Artia Global Partners LP 88,831$16,135,2635.96%
DAFNA Capital Management LLC 78,573$14,272,0004.28%
First Light Asset Management, LLC 243,675$44,261,1273.98%
CATALYST PRIVATE WEALTH, LLC 21,837$3,966,4732.74%
Sands Capital Ventures, LLC 58,895$10,697,6882.64%
ARCH Venture Management, LLC 30,000$5,449,2002.63%
Logos Global Management LP 100,000$18,164,0002.60%
View complete list of KARUNA THERAPEUTICS INC shareholders